Project

PH-L19IL2TNFNMSC-04/19 A phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions

Ongoing - recruitment active ยท 2020 until 2030

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2020
End Date
2030
Financing
Industry
Labels
non-melanoma
Brief description/objective